MCI
MNTA

McDonald Capital Investors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

McDonald Capital Investors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,100
Closed -$583K – 21
2020
Q3 		$583K Buy
+11,100
New +$459K 0.05% 18

McDonald Capital Investors's MNTA Position: Q4 2020 in Review

McDonald Capital Investors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 11,100 shares — an estimated $583K sold.

McDonald Capital Investors first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $583K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • McDonald Capital Investors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • McDonald Capital Investors sold 11,100 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $583K.
  • McDonald Capital Investors first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • McDonald Capital Investors's Momenta Pharmaceuticals, Inc. position peaked at $583K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on McDonald Capital Investors's 13F filing for Q4 2020, filed 5 Feb 2021.